ClinicalTrials.gg
RecruitingNCT06781892STRAT-DEFIUpdated May 23, 2025

Strategies for Defibrillation During Out-of-Hospital Cardiac Arrest

An interventional study of Anterior-lateral pad positioning and Anterior-posterior pad positioning in Cardiac Arrest (CA), sponsored by Lars Wiuff Andersen. Recruiting at 6 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-23.

Primary conditionOut-of-Hospital Cardiac ArrestRegistry: Heart ArrestReclassifiedWhy we changed it
Registry
Heart Arrest — the first condition term the registry derived for this study.
ClinicalTrials.gg
Out-of-Hospital Cardiac Arrest
Why
  1. The study's title name Out-of-Hospital Cardiac Arrest, a narrower term within Heart Arrest.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Lars Wiuff Andersen · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
909
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Out-of-Hospital Cardiac Arrest with a site in Denmark — 7 open to participants now, 8 under way, 2 of them phase 3. Out-of-Hospital Cardiac Arrest · Denmark.

Planned enrollment
11th of 26
909 · median 376
Started
2025
with 1 other
No phase
18 of 38
3 open now
Registered
37th of 38
by date
Lead sponsor
2 of 38
Lars Wiuff Andersen

Among the 38 studies in Out-of-Hospital Cardiac Arrest with a site in Denmark, this one is the 11th largest by planned enrollment of the 26 interventional ones that give a count, is one of 2 that started in 2025, is one of 18 with no phase, and was the 37th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

7 of the 38 studies in Out-of-Hospital Cardiac Arrest with a site in Denmark are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Out-of-Hospital Cardiac Arrest with a site in Denmark, or all of them as a file.
02

Study summary

The "Strategies for Defibrillation during Out-of-Hospital Cardiac Arrest" (STRAT-DEFI) trial is an investigator-initiated, individually randomized, 3-group clinical trial comparing standard anterior-lateral pad positioning with anterior-posterior positioning and double sequential defibrillation during adult out-of-hospital cardiac arrest.

03

Conditions studied

  • Cardiac Arrest (CA)

Browse trials for

Keywords

  • Out-of-hospital cardiac arrest
  • Defibrillation
  • Double-sequential defibrillation
04

In context

Out-of-Hospital Cardiac Arrest Reclassified

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

This study's planned enrollment of 909 is above the median of 218 across 179 interventional studies indexed under Out-of-Hospital Cardiac Arrest.

Browse Out-of-Hospital Cardiac Arrest studies →

Lead sponsor

Lars Wiuff Andersen is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Compared within Out-of-Hospital Cardiac Arrest, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Heart Arrest. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Out-of-hospital cardiac arrest
  2. Age ≥ 18 years
  3. ≥ 1 manual defibrillation attempt by emergency medical services
  4. Shockable rhythm as the last known rhythm
  5. Two manual defibrillators present on-site

Exclusion criteria

Exclusion Criteria:

  1. Blunt trauma, penetrating trauma, or burn injury suspected to be the cause of the cardiac arrest
  2. Prior enrollment in the trial
  3. Posterior pad placement not deemed possible by on-site clinician
06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
909 participants (estimated)

Study arms

  • Active comparator
    Anterior-lateral pad positioning

    Other: Anterior-lateral pad positioning

  • Experimental
    Anterior-posterior pad positioning

    Other: Anterior-posterior pad positioning

  • Experimental
    Double-sequential defibrillation

    Anterior-lateral pad positioning combined with anterior-posterior pad positioning for a total of 4 pads and 2 shocks.

    Other: Double-sequential defibrillation

Interventions

  • OtherAnterior-lateral pad positioning

    Defibrillation pads positioned anterior-lateral

  • OtherAnterior-posterior pad positioning

    Defibrillation pads positioned anterior-posterior

  • OtherDouble-sequential defibrillation

    Combination of anterior-lateral and anterior-posterior pad positioning for a total of 4 pads and 2 shocks.

07

What researchers measure

Primary outcomes

  1. Survival at 30 days

    Time frame: 30 days after the cardiac arrest

Secondary outcomes

  1. Survival at 90 days

    Time frame: 90 days after the cardiac arrest

  2. Favorable neurological outcome at 30 days

    Neurological outcome will be assessed with the modified Rankin Scale (mRS) which is a scale from 0 to 6 assessing neurological/functional outcomes after brain damage with higher scores indicating worse neurological/functional outcomes. The scale will will be dichotomized as favorable (mRS 0-3) vs. unfavorable (mRS 4-6).

    Time frame: 30 days after the cardiac arrest

  3. Favorable neurological outcome at 90 days

    Neurological outcome will be assessed with the modified Rankin Scale (mRS) which is a scale from 0 to 6 assessing neurological/functional outcomes after brain damage with higher scores indicating worse neurological/functional outcomes. The scale will will be dichotomized as favorable (mRS 0-3) vs. unfavorable (mRS 4-6).

    Time frame: 90 days after the cardiac arrest

08

Study locations

2 of 6 sites recruiting
  • Emergency Medical Services, the North Denmark Region
    Aalborg, 9000, Denmark
    Recruiting
    • Thomas L Klitgaard · Contacttlk@rn.dk · +4597662100
  • Danish Air Ambulance, Danish Regions
    Aarhus N, 8200, Denmark
    Not yet recruiting
  • Prehospital Emergency Medical Services, Central Denmark Region
    Aarhus N, 8200, Denmark
    Recruiting
  • Copenhagen Emergency Medical Services, the Capital Region of Denmark
    Ballerup, 2750, Denmark
    Not yet recruiting
  • The Prehospital Center, Region Zealand
    Næstved, 4700, Denmark
    Not yet recruiting
  • Emergency Medical Services, the Region of Southern Denmark
    Vejle, 7100, Denmark
    Not yet recruiting
09

References and documents

Individual participant data

Plan to share: Yes — De-identified data. All relevant trial-related documents, including the protocol, data dictionary, and the main statistical code, will be shared along with the data.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: After publication of the last results (i.e., 1-year follow-up), all de-identified individual patient data will be made available for data sharing as allowed within Danish law. There will be no predetermined end date for the data sharing.

Access criteria: Data will be available for any research purpose to all interested parties who have approval from an independent review committee if required and who have a methodological sound proposal as determined by the steering committee of the current trial. Only the methodological qualities and not the purpose or objective of the proposal will be considered. Interested parties will be able to request the data by contacting the principal investigator.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Mar 2028, 35 months after the start.

Of 93 non-industry interventional studies with no phase under Out-of-Hospital Cardiac Arrest, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's planned 35 months is close to that.

Counting every sponsor, half of 95 studies reached it within 34 months; a quarter within 19 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 14, 2025
First posted
Jan 17, 2025
StartActual
Mar 15, 2025
Primary completionEst.
Mar 1, 2028
CompletionEst.
Mar 1, 2029
Last update
May 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06781892
Lead sponsor
Lars Wiuff Andersen
Responsible party
Lars Wiuff Andersen (Professor, Aarhus University Hospital) — Sponsor-investigator
First posted
Jan 17, 2025
Start date
Mar 15, 2025
Primary completion
Mar 1, 2028 (estimated)
Completion
Mar 1, 2029 (estimated)
Last update
May 23, 2025

Study contacts

Lars W Andersen
Contact
lwandersen@clin.au.dk
+4578414848
Bertram L Kirkegaard
Contact
bertramkirkegaard@clin.au.dk

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion